Testing effectiveness (Phase 2)Looking for participantsNCT07179640
What this trial is testing
Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1
Who this might be right for
Hypophosphatasia (HPP)
Alesta Therapeutics 120